CAPTRUST Financial Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $315K | Sell |
4,810
-274
| -5% | -$18K | ﹤0.01% | 2020 |
|
|
2025
Q1 | $359K | Buy |
5,084
+59
| +1% | +$4.16K | ﹤0.01% | 1843 |
|
|
2024
Q4 | $330K | Buy |
5,025
+171
| +4% | +$11.2K | ﹤0.01% | 1851 |
|
|
2024
Q3 | $343K | Sell |
4,854
-53
| -1% | -$3.74K | ﹤0.01% | 1809 |
|
|
2024
Q2 | $325K | Sell |
4,907
-209
| -4% | -$13.9K | ﹤0.01% | 1767 |
|
|
2024
Q1 | $347K | Sell |
5,116
-704
| -12% | -$47.8K | ﹤0.01% | 1687 |
|
|
2023
Q4 | $360K | Buy |
+5,820
| New | +$360K | ﹤0.01% | 1988 |
|
|
2022
Q1 | – | Sell |
-849
| Closed | -$56K | – | 5010 |
|
|
2021
Q4 | $56K | Buy |
+849
| New | +$56K | ﹤0.01% | 2578 |
|
|
2021
Q3 | – | Sell |
-108
| Closed | -$7K | – | 4696 |
|
|
2021
Q2 | $7K | Buy |
+108
| New | +$7K | ﹤0.01% | 3705 |
|
|
2014
Q3 | – | Sell |
-459
| Closed | -$21K | – | 87 |
|
|
2014
Q2 | $21K | Buy |
+459
| New | +$21K | ﹤0.01% | 110 |
|